Amgen | AMGN - 売上総利益

株価
337.87
毎日の変更
-1.70 -0.50%
毎月
-3.19%
毎年
16.14%
Q2 予測
337.18




売上総利益 変化する 日付
AbbVie USD 10.47B 605M 2025-09
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
ALKERMES USD 338.34M 72.51M 2025-12
Amgen USD 6.48B 307M 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Coherus Biosciences USD 8.7M 853K 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Exelixis USD 572.18M 7M 2025-12
Genmab DKK 977M 13M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Glaxosmithkline GBP 8.75B 2.92B 2025-09
Incyte USD 1.17B 217.51M 2026-03
Ionis Pharmaceuticals USD 195M 40M 2025-12
J&J USD 17.24B 642M 2026-03
Merck USD 13.42B 431M 2025-09
Moderna USD 226M 583M 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Novartis USD 10.82B 694M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Takeda JPY 790.55B 262.97B 2025-12
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12